Nocturnal Blood Pressure Non-Dipping as an Autonomic Biomarker of Psychosis and Movement Disorder Severity in Pediatric Epilepsy
Objective: To investigate the association between 24-hour ambulatory blood pressure monitoring (ABPM) patterns, particularly nocturnal non-dipping, and psychosis severity, movement disorder burden, and non-motor symptoms…Psychosis in Parkinson’s Disease Patients Treated with Continuous Subcutaneous Foslevodopa/Foscarbidopa: A Real-World Observational Study.
Objective: To assess the incidence and timing of psychosis (hallucinations and delusions) in Parkinson’s disease patients receiving continuous subcutaneous infusion of foslevodopa/foscarbidopa (CSFLI). Background: CSFLI…A Case of NUS1 Spectrum Disorder with Adult-Onset Psychosis
Objective: To report a novel case of NUS1 spectrum with childhood-onset abnormal movements and adult-onset psychiatric manifestations. Background: The NUS1 gene is associated with developmental…Psychotic Symptoms and Cognitive Impairment in Huntington’s Disease
Objective: To investigate the clinical and cognitive correlates of psychotic symptoms in patients with Huntington’s disease (HD). Background: Psychiatric manifestations are common in HD, but…Sex Differences for Primary Psychiatric Diagnoses and Associated Care Outcomes in Dementia with Lewy Bodies using Epic Cosmos
Objective: Assess sex differences for documented primary psychiatric diagnoses in people with dementia with Lewy bodies (DLB) and their associations with care outcomes (hospitalization, specialty…Predictors of Severity of Psychosis in Parkinson’s Disease: A 3-year longitudinal cohort study
Objective: To determine which disease-related variables are independently associated with severity of psychosis in Parkinson’s Disease. Background: Parkinson’s disease (PD) is a multisystem disorder in…Electrophysiological Evaluation of Visual Hallucination in Parkinson’s Disease Psychosis
Objective: Our understanding of the psychosis in Parkinson’s disease (PDPsy) is incomplete, and standard of care treatment with antipsychotics has its limitations. Neuroimaging and histopathology in PDPsy reveal that visual hallucinations (VHs), the hallmark of psychosis in PDPsy, arise…Parkinson disease psychosis: A systematic review and meta-analysis
Objective: To determine the prevalence of Parkinson disease psychosis (PDP) as a function of several putative risk factors: PD duration, age, cognitive impairment, dopaminergic or…Impact of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion on Neuropsychiatric Symptoms in Clinical Practice: A Multicenter Study
Objective: To determine the incidence and risk factors of neuropsychiatric adverse events (AEs) in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa continuous subcutaneous infusion…Severity of Psychotic Symptoms Is Independently Associated with Caregiver Burden in Parkinson’s Disease: A Cross-Sectional Analysis
Objective: To evaluate the association between psychotic symptom severity and caregiver burden in patients with PD. Background: Psychotic symptoms are common in Parkinson’s disease (PD)…
- 1
- 2
- 3
- …
- 14
- Next Page »